Efficacy, Safety, and Tolerability of JNJ-27018966 (Eluxadoline) in the Treatment of Irritable Bowel Syndrome With Diarrhea
Clinical trial NCT01130272 · COMPLETED
Trial details
- NCT number
- NCT01130272
- Sponsor
- Furiex Pharmaceuticals, Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-04-28
- Primary completion
- 2011-07-14
- Enrollment
- 807
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.